These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 25266217)
21. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection. Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278 [TBL] [Abstract][Full Text] [Related]
22. The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. Mahmoud MR; El-Abhar HS; Saleh S J Ethnopharmacol; 2002 Jan; 79(1):1-11. PubMed ID: 11744288 [TBL] [Abstract][Full Text] [Related]
23. Parasitological and histopathological studies to the effect of aqueous extract of Moringa oleifera Lam. leaves combined with praziquantel therapy in modulating the liver and spleen damage induced by Schistosoma mansoni to male mice. Saad El-Din MI; Gad El-Hak HN; Ghobashy MA; Elrayess RA Environ Sci Pollut Res Int; 2023 Feb; 30(6):15548-15560. PubMed ID: 36169837 [TBL] [Abstract][Full Text] [Related]
24. In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni. Mokbel KEM; Baiuomy IR; Sabry AEA; Mohammed MM; El-Dardiry MA Sci Rep; 2020 Sep; 10(1):15742. PubMed ID: 32978497 [TBL] [Abstract][Full Text] [Related]
25. An adjuvant effect of Metformin as an anti-fibrotic agent when administered with the anti-schistosomal Praziquantel in Schistosoma mansoni infected mice. Salama WM; El-Naggar SA; Harras SF; El-Said KS Trop Biomed; 2021 Jun; 38(2):205-213. PubMed ID: 34172712 [TBL] [Abstract][Full Text] [Related]
26. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates. Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier. Tawfeek GM; Baki MHA; Ibrahim AN; Mostafa MAH; Fathy MM; Diab MSEDM Parasitol Res; 2019 Dec; 118(12):3519-3533. PubMed ID: 31673833 [TBL] [Abstract][Full Text] [Related]
28. Protective role of Balanities aegyptiaca fruit aqueous extract in mice infected with Schistosoma mansoni. Elmalawany AM; Osman GY; Elashwal MS; Mohamed AH Exp Parasitol; 2022 Aug; 239():108290. PubMed ID: 35779646 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic effects of Allium sativum and Allium cepa in Schistosoma mansoni experimental infection. Mantawy MM; Ali HF; Rizk MZ Rev Inst Med Trop Sao Paulo; 2011; 53(3):155-63. PubMed ID: 21755238 [TBL] [Abstract][Full Text] [Related]
30. Effect of combined praziquantel and recombinant glutathione S-transferase on resistance to reinfection in murine Schistosomiasis mansoni. Botros SS; Makary EA; Ahmed KM; Ibrahim AM; Nashed NN; El-Nahal HM; Doughty BL; Hassanein HI Int J Immunopharmacol; 2000 Nov; 22(11):979-88. PubMed ID: 11090706 [TBL] [Abstract][Full Text] [Related]
31. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study. Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884 [TBL] [Abstract][Full Text] [Related]
32. Niosomes for enhanced activity of praziquantel against Schistosoma mansoni: in vivo and in vitro evaluation. Zoghroban HS; El-Kowrany SI; Aboul Asaad IA; El Maghraby GM; El-Nouby KA; Abd Elazeem MA Parasitol Res; 2019 Jan; 118(1):219-234. PubMed ID: 30421348 [TBL] [Abstract][Full Text] [Related]
33. Pathological and immunological evaluation of different regimens of praziquantel treatment in a mouse model of Schistosoma mansoni infection. Membe Femoe U; Boukeng Jatsa H; Greigert V; Brunet J; Cannet C; Kenfack MC; Gipwe Feussom N; Kadji Fassi JB; Tienga Nkondo E; Abou-Bacar A; Pfaff AW; Dimo T; Kamtchouing P; Tchuem Tchuenté LA PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010382. PubMed ID: 35446855 [TBL] [Abstract][Full Text] [Related]
34. Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study. Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; El-Karef AA; Abou-El-Wafa HS Biomed Pharmacother; 2017 Nov; 95():1346-1358. PubMed ID: 28946182 [TBL] [Abstract][Full Text] [Related]
35. Combination therapy using Pentostam and Praziquantel improves lesion healing and parasite resolution in BALB/c mice co-infected with Leishmania major and Schistosoma mansoni. Khayeka-Wandabwa C; Kutima H; Nyambati VC; Ingonga J; Oyoo-Okoth E; Karani L; Jumba B; Githuku K; Anjili CO Parasit Vectors; 2013 Aug; 6():244. PubMed ID: 23968249 [TBL] [Abstract][Full Text] [Related]
36. Use of kinase inhibitors against schistosomes to improve and broaden praziquantel efficacy. Nawaratna SSK; McManus DP; Gasser RB; Brindley PJ; Boyle GM; Rivera V; Ranasinghe SL; Jones MK; You H; Gobert GN Parasitology; 2020 Nov; 147(13):1488-1498. PubMed ID: 32741402 [TBL] [Abstract][Full Text] [Related]
37. In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni. Allam G; Eweas AF; Abuelsaad AS Parasitol Res; 2013 Sep; 112(9):3137-49. PubMed ID: 23793335 [TBL] [Abstract][Full Text] [Related]
38. Treatment of acute schistosomiasis mansoni with praziquantel and an antifibrotic agent in mice. Maintenance of resistance to infection. Hassan SI; Ali I; Nessim NG; Amer NM; Abd el Kader el Khafif M; Ashour A; el Mohandes M Arzneimittelforschung; 2003; 53(6):440-4. PubMed ID: 12872615 [TBL] [Abstract][Full Text] [Related]
39. Laboratory induced resistance to praziquantel in experimental schistosomiasis. Ismail MM; Taha SA; Farghaly AM; el-Azony AS J Egypt Soc Parasitol; 1994 Dec; 24(3):685-95. PubMed ID: 7844435 [TBL] [Abstract][Full Text] [Related]
40. Experimental schistosomiasis mansoni: modulation of granulomas by inhibition of collagen cross-link formation. Preliminary report. Giboda M; Zenka J; Julis I; Vítovec J Ann Trop Med Parasitol; 1992 Dec; 86(6):631-6. PubMed ID: 1304705 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]